Status | Study |
Not yet recruiting |
Study Name: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma Condition: Adult T-Cell Leukemia/Lymphoma Anaplastic Large Cell Lymphoma, ALK-Negative Date: 2017-04-10 Interventions: Drug: Brentuximab Vedotin Give |
Recruiting |
Study Name: Comparison Between Axial- and Lateral-viewing Capsule Endoscopy in Celiac Disease Condition: Celiac Disease Date: 2017-03-20 Interventions: Device: Lateral-viewing CapsoCam device |
Not yet recruiting |
Study Name: Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm Hepatosplenic T-Cell Lymphoma Date: 2017-03-01 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas Condition: Lymphoma, Large-Cell, Anaplasitc Hodgkin Disease Lymphoma, Date: 2017-02-09 Interventions: Biological: Anti-CD30-CAR T cells |
Recruiting |
Study Name: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma Condition: Acute Myeloid Leukemia Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Date: 2016-03-31 Interventions: Biological: anti-CD7 CAR-pNK cells The allogeneic NK cells (NK-92 cell line for clinical use) are engine |
Recruiting |
Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Condition: Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult T-Cell Leukemia/Lymphoma Date: 2016-01-08 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) Condition: T-cell Lymphoma Angioimmunoblastic T-cell Lymphoma Hepato- Date: 2015-10-26 Interventions: Drug: Brentuximab vedotin study drug given intravenously to determine efficacy in study diseases |
Recruiting |
Study Name: Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma Condition: Anaplastic Large Cell Lymphoma, ALK-Negative Anaplastic Large Cell Lymphoma, ALK-Positive Date: 2015-09-24 Interventions: Drug: Cyclophosphamide Given I |
Recruiting |
Study Name: MAgnetic Resonance Imaging in COeliac Disease Condition: Celiac Disease Coeliac Disease Celiac Sprue Date: 2015-09-08 Interventions: Other: Gluten free diet Patients will follow a gluten free diet |
Recruiting |
Study Name: CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Condition: Peripheral T-Cell Lymphoma Angioimmunoblastic T Cell Lymphoma Date: 2015-07-18 Interventions: Drug: CEOP/IVE/GDP chemotherapy regimen |